36
6
23
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10484 |
BCL2-IN-1
|
Others | Others |
BCL2-IN-1 is a potent Bcl-2 inhibitor (Ki <0.01 nM). | |||
T10485 |
PROTAC Bcl2 degrader-1
|
BCL; PROTACs | Apoptosis; PROTAC |
PROTAC Bcl2 degrader-1 is a PROTAC, which potently and selectively induces the degradation of Mcl-1 (IC50: 11.81 μM) and Bcl-2 (IC50: 4.94 μM; DC50: 3.0 μM). | |||
T78813 |
CDK2/Bcl2-IN-1
|
CDK | Cell Cycle/Checkpoint |
CDK2/Bcl2-IN-1(化合物1)为皂素类CDK-2抑制剂(IC50=117.6 nM),对癌细胞显示显著细胞毒性,并能够抑制Bcl-2,诱导A549肺癌细胞的凋亡。 | |||
T6778 |
BDA-366
|
BCL | Apoptosis |
BDA-366 是一种有效的 Bcl2 拮抗剂,以高亲和力和选择性 (Ki = 3.3 nM) 结合 Bcl2-BH4 结构域。 BDA-366 诱导 Bcl2 的构象变化,从而消除其抗凋亡功能,将其从存活分子转变为细胞死亡诱导剂。 BDA-366 抑制肺癌细胞的生长。 | |||
T20533 |
NNK
Nicotine-derived nitrosamine ketone |
Lipoxygenase | Metabolism |
NNK (Nicotine-derived nitrosamine ketone) 是尼古丁亚硝化衍生物。它可以激活 ERK1/2和 PKCα,并在 Ser70 激活 Bcl2磷酸化,以及在 Thr58和 Ser62激活 c-Myc。它可用于构建肺癌小鼠模型,以及诱导人肺癌细胞的增殖和存活。 | |||
T14376 |
AZD4320
|
BCL | Apoptosis |
AZD4320 是一种BCL2/BCLxL 双重抑制剂,是 BH-3 类似物,对 KPUM-MS3、KPUM-UH1 和 STR-428 细胞,IC50 值分别为 26 nM、17 nM 和 170 nM。 | |||
T22094 |
JGB1741
ILS-JGB-1741 |
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
JGB1741 (ILS-JGB-1741) 是一种有效的选择性 SIRT1 抑制剂,IC50 为 15 μM。 JGB1741 调节 Bax/Bcl2 比率、细胞色素 c 释放和 PARP 裂解并增加乙酰化 p53 水平,导致 p53 介导的细胞凋亡。 JGB1741可用于乳腺癌研究。 | |||
T1980 |
HA14-1
|
BCL | Apoptosis |
HA14-1 是一种 Bcl-2/Bcl-xL 拮抗剂,与 Bcl-2 上的特定口袋结合,IC50约为 9 μM。 | |||
T12824L |
S55746
BLC201 |
BCL | Apoptosis |
S55746 (BLC201) 是一种有效、可口服、选择性的BCL-2抑制剂,其Ki 值和Kd 值分别为 1.3 nM 和 3.9 nM。它具有抗肿瘤活性且毒性低。 | |||
T32147 |
IMC-76
NSC-59276,IMC 76,NSC 59276,NSC59276 |
||
IMC-76 is a BCL2 i-motif-interactive compound that can act by destabilizing or unfolding the i-motif. | |||
T6275 |
Obatoclax Mesylate
Obatoclax,GX15-070,奥巴克拉甲磺酸盐 |
BCL; Parasite; Autophagy | Apoptosis; Autophagy; Microbiology/Virology |
Obatoclax Mesylate (GX15-070) 是泛 BCL-2家族蛋白抑制剂,对 BCL-2 的 Ki 值为 220 nM。它是 BH3 模拟物,具有抗癌和广谱抗寄生虫活性。它诱导自噬依赖性细胞死亡,并靶向细胞周期蛋白 D1 进行蛋白酶体降解。 | |||
T32146 |
IMC-48
NSC 138948,NSC-138948,IMC48,NSC138948 |
||
IMC-48, as a BCL2 i-motif-interactive compound, can act by stabilizing or facilitating the folding of the i-motif. | |||
T10483 |
Lisaftoclax
Bcl-2/Bcl-xl inhibitor 1,APG-2575 |
BCL | Apoptosis |
Lisaftoclax (Bcl-2/Bcl-xl inhibitor 1) 是一种双重 Bcl-2 和 Bcl-xl 抑制剂(IC50:2 nM 和 5.9 nM),具有抗肿瘤活性。 | |||
T74637 |
Sonrotoclax
|
||
Sonrotoclax为一种口服有效的Bcl2抑制剂,对多种淋巴瘤和白血病细胞系展现出显著的细胞杀伤能力。 | |||
T14071 |
A-385358
|
BCL | Apoptosis |
A-385358 是一种特异性 Bcl-xL 抑制剂,对 Bcl-xL 和 Bcl-2 的 Ki 分别为 0.80 nM 和 67 nM。 | |||
T73792 |
(S)-(-)-Perillic acid
|
||
(S)-(-)-Perillic acid 是一种萜类植物提取物,具有抗菌和抗癌活性。(S)-(-)-Perillic acid 诱导细胞凋亡和细胞周期阻滞,增加细胞内 Bax,Bcl2,p21和 caspase-3的蛋白水平。(S)-(-)-Perillic acid 可用于癌症和感染研究。 | |||
T6281 |
TW-37
TW 37 |
BCL | Apoptosis |
TW-37 是重组 Bcl-2、Bcl-xL 和 Mcl-1 的非肽抑制剂,Ki 值分别为 0.26、0.29和1.11μM | |||
T6396 |
(R)-(-)-Gossypol acetic acid
(-)-Gossypol acetic acid,AT-101 (acetic acid),(R)-Gossypol acetic acid,AT101醋酸,AT101,AT101 acetate |
BCL; Autophagy | Apoptosis; Autophagy |
(R)-(-)-Gossypol acetic acid (AT101 acetate) 是天然产物 Gossypol 的左旋异构体,与 Bcl-2、Bcl-xL 和 Mcl-1 结合,Ki 为 0.32 μM、0.48 μM 和 0.18 μM。 | |||
T6650 |
Sabutoclax
BI-97C1 |
BCL | Apoptosis |
Sabutoclax (BI-97C1) 是一种泛 Bcl-2 抑制剂,包括 Bcl-xL、Bcl-2、Mcl-1 和 Bfl-1,IC50 分别为 0.31 μM、0.32 μM、0.20 μM 和 0.62 μM。 | |||
T6749 |
A-1331852
|
BCL | Apoptosis |
A1331852是一种具有口服活性的BCL-XL 选择性抑制剂,Ki 值小于10 pM。它可用于治疗癌症、免疫和自身免疫疾病。 | |||
T2119 |
Venetoclax
GDC-0199,ABT 199,维奈妥拉,ABT-199,ABT199 |
BCL; Autophagy | Apoptosis; Autophagy |
Venetoclax (ABT-199) 是一种 Bcl-2 抑制剂 (Ki<0.01 nM),具有高效性、选择性和口服活性。Venetoclax 与 Bcl-xL 和 Bcl-W 的亲和力降低了 3 个数量级(Kis=48/245 nM)。Venetoclax 可以诱导自噬和凋亡。 | |||
T29172 |
YD277
YD 277,YD-277 |
||
YD277 is a small molecule derived from ML264, a KLF5 inhibitor that elicits cytotoxic effects in colon cancer cell lines. YD277 significantly induced G1 cell cycle arrest and apoptosis in MDA-MB-231 and MDA-MB-468 TNBC cells, independent of KLF5 inhibitio | |||
T63521 | Bcl-2-IN-7 | ||
Bcl-2-IN-7 是 Bcl-2(b 细胞淋巴瘤 -2) 的有效抑制剂,能够下调 Bcl-2 的表达,提高 p53、Bax、caspase-7 mRNA 的表达,能够诱导乳腺癌 MCF-7 细胞周期阻滞和凋亡。Bcl-2-IN-7 对 MCF-7 细胞 (IC50: 20.17 μM)、LoVo 细胞 (IC50: 22.64 μM)、HepG2 细胞 (IC50:45.57 μM) 和 A549 细胞 (IC50: 51.50 μM)均表现出良好的抗肿瘤活性。 | |||
T63676 | Bcl-2-IN-6 | ||
Bcl-2-IN-6 是 Bcl-2 (b 细胞淋巴瘤-2) 的有效抑制剂,可下调 Bcl-2 的表达,并提高 p53、Bax、caspase-7 mRNA 的表达。Bcl-2-IN-7 能够诱导乳腺癌 MCF-7 细胞周期阻滞和凋亡。Bcl-2-IN-7 能够作用于 MCF-7 细胞 (IC50: 20.91 μM)、LoVo 细胞 (IC50: 22.30 μM)、HepG2 细胞 (IC50: 42.29 μM) 和 A549 细胞 (IC50: 48.00 μM) 均显示出良好的抗肿瘤效果。 | |||
T2101 |
Navitoclax
ABT-263 |
BCL | Apoptosis |
Navitoclax (ABT-263) 是一种 Bcl-2 抑制剂,可与 Bcl-xL、Bcl-2、Bcl-w 等蛋白结合 (Ki<1 nM),具有有效性和口服活性。Navitoclax 具有抗肿瘤活性,可以诱导细胞凋亡。 | |||
T2099 |
ABT-737
|
Mitophagy; BCL; Autophagy | Apoptosis; Autophagy |
ABT737 是 BH3 模拟物,是Bcl-2、Bcl-xL 和Bcl-w 抑制剂,EC50分别为 30.3 nM、78.7 nM 和 197.8 nM。它诱导自噬,有研究急性髓系白血病的潜力。它还诱导 BCL-2/BAX 复合物的破坏和 BAK 依赖性。 | |||
T11968 |
MCL-1/BCL-2-IN-1
|
BCL | Apoptosis |
MCL-1/BCL-2-IN-2 (Compound Nap-1) 是一种有效的选择性 Mcl-1和 Bcl-2双重抑制剂,IC50分别为 4.45 和 3.18 μM。 | |||
T11973 |
Mcl1-IN-11
|
BCL | Apoptosis |
Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively. | |||
T10577 |
BM 957
|
BCL | Apoptosis |
BM 957 is an effective Bcl-2 and Bcl-xL inhibitor (Kis: 1.2 and <1 nM; IC50s: 5.4 and 6.0 nM). | |||
T11974 | Mcl1-IN-12 | BCL | Apoptosis |
Mcl1-IN-12 has anti-tumor activity.It is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.29 and 3.1 μM, respectively. | |||
T79171 |
Bcl-2-IN-11
|
||
Bcl-2-IN-11(compound 6)是高效选择性的Bcl-2抑制剂,具有0.9 nM的IC50。相对于Bcl-xl,其抑制作用较弱(IC50 > 1000 nM)。该化合物主要用于研究因Bcl-2家族蛋白过量表达引起的多种癌症,尤其适用于急性淋巴性白血病等恶性血液疾病。同时,Bcl-2-IN-11可以减少由Bcl-xl抑制相关的副作用,例如减少血小板。 | |||
T39961 |
Bcl-2-IN-2
|
||
Bcl-2-IN-2 is a highly potent and selective inhibitor targeting Bcl-2 and Bcl-xL. It displays an IC50 value of 0.034 nM, suggesting its strong inhibitory activity specifically against Bcl-2. Additionally, Bcl-2-IN-2 exhibits an IC50 value of 43 nM against Bcl-xL, demonstrating over 1000-fold selectivity for Bcl-2 compared to Bcl-xL. | |||
T12824 |
S55746 hydrochloride
BLC201 (hydrochloride) |
BCL | Apoptosis |
S55746 hydrochloride is a potent, orally active and selective inhibitor of BCL-2(Ki of 1.3 nM and a Kd of 3.9 nM),with antitumor activity with low toxicity. | |||
T38810 |
BM-1197
|
||
BM-1197, a highly potent and specific dual inhibitor of Bcl-2 and Bcl-xL, effectively targets these proteins with IC50 values of 3.5 nM and 5.2 nM for Bcl-2 and Bcl-xL, respectively. This compound demonstrates notable antitumor activity in both in vitro and in vivo settings. | |||
T40230 |
Mcl-1 inhibitor 6
|
||
Mcl-1 inhibitor 6 is a potent, orally active chemical compound that selectively inhibits the myeloid cell leukemia 1 (Mcl-1) protein, with a high affinity (K d = 0.23 nM) and binding activity (K i = 0.02 μM). This compound exhibits exceptional selectivity over other members of the Bcl-2 family, including Bcl-2, Bcl2A1, Bcl-xL, and Bcl-w (K d >10 μM). Notably, Mcl-1 inhibitor 6 demonstrates strong antitumor activity. | |||
T13459 |
(+)-Apogossypol
Apogossypol,NSC736630 |
Others | Others |
(+)-Apogossypol is an antagonist of pan-BCL-2. (+)-Apogossypol binds to Mcl-1(Bcl-2 and Bcl-xL with EC50s of 2.6, 2.8 and 3.69 µM, respectively). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1079 |
Metronidazole
Flagyl,Metronidazol,甲硝唑,Anagiardil |
Apoptosis; NADPH; Hydrogenase; Antibacterial; Antibiotic; Parasite; Antifection | Apoptosis; Metabolism; Microbiology/Virology |
Metronidazole (Metronidazol) 是一种合成的硝基咪唑衍生物,具有抗原生动物和抗菌活性。 | |||
T6917 |
Oleuropein
洋橄榄苦甙,橄榄苦苷 |
Apoptosis; Aromatase; ROS; PPAR | Apoptosis; DNA Damage/DNA Repair; Endocrinology/Hormones; Immunology/Inflammation; Metabolism |
Oleuropein 在橄榄叶和油中发现的天然产物,通过 p53 依赖性途径以及 Bax 和 Bcl2基因的调控来诱导乳腺癌细胞凋亡,还抑制芳香化酶。它可通过直接抑制 PPARγ转录活性来发挥抗氧化,抗炎和抗动脉粥样硬化作用。 | |||
TN1379 |
Alphitolic acid
麦珠子酸 |
NF-κB; Akt; p53 | Apoptosis; Cytoskeletal Signaling; NF-κB; PI3K/Akt/mTOR signaling |
Alphitolic acid is a potent Hh/GLI signaling inhibitor, it shows an important relationship between Hh/GLI signaling inhibition, the decrease of BCL2, and cytotoxicity against cancer cells. | |||
T6518 |
Gossypol
Pogosin,BL 193,棉酚,NSC 56817 |
BCL; Dehydrogenase | Apoptosis; Metabolism |
Gossypol (BL 193) 是一种多酚醛,可渗透细胞并作为几种脱氢酶的抑制剂。它分别与 Bcl-xL 蛋白和Bcl-2蛋白结合,Ki 值分别为 0.5-0.6 μM 和 0.2-0.3 mM。 | |||
T2730 |
Gossypol (acetic acid)
(±)-Gossypol-acetic acid,Pogosin,AT101,醋酸棉酚,乙酸棉子酚,Gossypol acetic acid |
BCL | Apoptosis |
Gossypol acetic acid (AT101) 是一种从棉籽中分离出来的多酚天然产物,分别与 Bcl-xL 蛋白和 Bcl-2蛋白结合,Ki 值分别为 0.5-0.6 μM 和 0.2-0.3 mM。 | |||
T6185 |
Gambogic Acid
藤黄酸,Beta-Guttiferrin,藤黄酸 A,Guttatic Acid,Guttic Acid |
BCL; Autophagy | Apoptosis; Autophagy |
Gambogic Acid (Guttic Acid) 是来自藤黄树的一种藤黄树脂,抑制 Bcl-XL、Bcl-2、Bcl-W、Bcl-B、Bfl-1和 Mcl-1,IC50分别为 1.47 μM、1.21 μM、2.02 μM、0.66 μM、1.06 μM 和 0.79 μM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03245 |
BCL2 Protein, Rat, Recombinant (His)
Bcl2,Apoptosis regulator Bcl-... |
Rat | E. coli |
BCL2 Protein, Rat, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 28.1 kDa and the accession number is P49950. | |||
TMPY-02700 |
BCL2 Protein, Human, Recombinant (His)
Bcl-2,PPP1R50,B-cell CLL/lymphoma 2 |
Human | E. coli |
BCL2 (B-cell leukemia/lymphoma 2, N-Histidine-tagged), also known as Bcl-2, belongs to the Bcl-2 family. Bcl-2 family proteins regulate and contribute to programmed cell death or apoptosis. It is a large protein family and all members contain at least one of four BH (bcl-2 homology) domains. Certain members such as Bcl-2, Bcl-xl and Mcl1 are anti-apoptotic, whilst others are pro-apoptotic. Most Bcl-2 family members contain a C-terminal transmembrane domain that functions to target these proteins... | |||
TMPH-02520 |
BCL2 Protein, Mouse, Recombinant (His)
Bcl2,Apoptosis regulator Bcl-... |
Mouse | E. coli |
BCL2 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 26.7 kDa and the accession number is P10417. | |||
TMPY-02431 |
BCL-XL Protein, Human, Recombinant (His)
bcl-xS,PPP1R52,Bcl-X,BCL... |
Human | E. coli |
BCL-XL Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 25.2 kDa and the accession number is A0A0S2Z3C5. | |||
TMPY-03434 |
BMF Protein, Human, Recombinant (His)
Bcl2 modifying factor |
Human | E. coli |
BMF(Bcl2 modifying factor) belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. BMF contains a single BCL2 homology domain 3 (BH3), and has been shown to bind BCL2 proteins and function as an apoptotic activator. BMF is found to be sequestered to myosin V motors by its association with dynein light chain 2, which may be important for sensing intracellular d... | |||
TMPY-03748 |
BCL2L12 Protein, Human, Recombinant (GST)
BCL2-like 12 (proline rich) |
Human | E. coli |
BCL2-like 12 (BCL2L12 ) is a new member of the apoptosis-related BCL2 gene family, members of which are implicated in various malignancies. The mRNA expression of BCL2L12 may constitute a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. BCL2L12 is a recently identified gene belonging to the BCL2 family, members of which are implicated in hematologic malignancies, including chronic lymphocytic leukemia (CLL). BCL2L12 can be considered as a new independent prog... | |||
TMPY-02004 |
BCL-W Protein, Human, Recombinant (His)
BCL2-L-2,BCL-W,BCL |
Human | E. coli |
BCL-W Protein, Human, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 20 kDa and the accession number is Q92843-1. | |||
TMPY-02564 |
BCL-XL Protein, Mouse, Recombinant (aa 1-212, His)
bcl2-L-1,Bcl-XL,BCL2... |
Mouse | E. coli |
BCL-XL Protein, Mouse, Recombinant (aa 1-212, His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 25.2 kDa and the accession number is Q64373-1. | |||
TMPY-03974 |
Bim Protein, Human, Recombinant (His)
BAM,BCL2-like 11 (apoptosis facilitator),B... |
Human | E. coli |
BCL2L11, also known as Bim, belongs to the BCL-2 protein family. Members of this family form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. BCL2L11 contains a Bcl-2 homology domain 3 (BH3). It has been shown to interact with other members of the BCL-2 protein family, including BCL2, BCL2L1/BCL-X(L), and MCL1, and to act as an apoptotic activator. BCL2L11 gene functions as an essential initiator of apoptosis in thymoc... | |||
TMPY-02376 |
BNIP3L Protein, Human, Recombinant
BCL2/adenovirus E1B 19kDa interacting prot... |
Human | E. coli |
The deletion of BNIP3L results in retention of mitochondria during lens fiber cell remodeling, and that deletion of BNIP3L also results in the retention of endoplasmic reticulum and Golgi apparatus. BNIP3L localizes to the endoplasmic reticulum and Golgi apparatus of wild-type newborn mouse lenses and is contained within mitochondria, endoplasmic reticulum and Golgi apparatus isolated from adult mouse liver. As the cells become packed with keratin bundles, Bnip3L expression triggers mitophagy to... | |||
TMPH-02536 |
BNIP3 Protein, Mouse, Recombinant (Cell-Free, His)
Bnip3,BCL2/adenovirus E1B 19 kDa protein-i... |
Mouse | E. coli |
Apoptosis-inducing protein that can overcome BCL2 suppression. May play a role in repartitioning calcium between the two major intracellular calcium stores in association with BCL2. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP... | |||
TMPH-02537 |
BNIP3 Protein, Mouse, Recombinant (His)
Bnip3,Nip3,BCL2/adenovirus E1B 19 kDa prot... |
Mouse | E. coli |
BNIP3 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with N-6xHis tag. The predicted molecular weight is 21.6 kDa and the accession number is O55003. | |||
TMPY-04936 |
BCL2A1 Protein, Human, Recombinant (His)
BFL1,ACC1,ACC-2,GRS,ACC-1,HBPA1,BCL2 |
Human | E. coli |
B-cell lymphoma 2-related protein A1 (BCL2A1) is a member of the BCL-2 family of anti-apoptotic proteins that confers resistance to treatment with anti-cancer drugs. Immunohistochemical expression of Wnt11 and BCL2A1 in complete moles and normal villi. Bcl2 family proteins control mitochondrial apoptosis and its members exert critical cell type and differentiation stage-specific functions, acting as barriers against autoimmunity or transformation. Anti-apoptotic Bcl2a1/Bfl1/A1 is frequently der... | |||
TMPH-01004 |
Beclin-1 Protein, Human, Recombinant (His)
Protein GT197,GT197,Coiled-coil myosin-like BCL... |
Human | E. coli |
Beclin-1 Protein, Human, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 57.9 kDa and the accession number is Q14457. | |||
TMPH-02538 |
Beclin-1 Protein, Mouse, Recombinant (His & SUMO)
Beclin-1,GT197,Coiled-coil myosin-like BCL2 |
Mouse | E. coli |
Plays a central role in autophagy. Acts as core subunit of different PI3K complex forms that mediate formation of phosphatidylinositol 3-phosphate and are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and required for the abcission step in cytokinesis, probably in the context of PI3KC3-C2. Essential f... | |||
TMPJ-00584 |
Bc1-w Protein, Human, Recombinant (His)
Apoptosis Regulator Bcl-W,KIAA0271,Bcl... |
Human | E. coli |
Bcl-2-like protein 2 (BCL2L2) belongs to the Bcl-2 family. BCL2L2 is highly expressed in thebrain, spinal cord, testis, pancreas, heart, spleen, and mammary glands. BCL2L2 is a peripheral membrane protein containing three motifs, BH1, BH2 and BH4. The BH4 motif appears to be involved in the anti-apoptotic function. The BH1 and BH2 motifs form a hydrophobic groove which acts as a docking site for the BH3 domain of some pro-apoptotic proteins. BCL2L2 promotes cell survival and blocks dexamethasone... | |||
TMPH-01605 |
BAG6 Protein, Human, Recombinant (E. coli, His & Myc)
BAT3,BAG6,HLA-B-associated transcript 3,BCL2 |
Human | E. coli |
BAG6 Protein, Human, Recombinant (E. coli, His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 41.7 kDa and the accession number is P46379. | |||
TMPH-01606 |
BAG6 Protein, Human, Recombinant (His & Myc)
BAG-6,Protein G3,BAG family molecular chaperone regulator 6,... |
Human | Baculovirus Insect Cells |
BAG6 Protein, Human, Recombinant (His & Myc) is expressed in Baculovirus insect cells with N-10xHis and C-Myc tag. The predicted molecular weight is 38.7 kDa and the accession number is P46379. | |||
TMPH-02650 |
FCMR/FAIM3 Protein, Mouse, Recombinant (His & SUMO)
|
Mouse | E. coli |
May play a role in the immune system processes. Protects cells from FAS-, TNF alpha- and FADD-induced apoptosis without increasing expression of the inhibitors of apoptosis BCL2 and BCLXL. Seems to activate an inhibitory pathway that prevents CASP8 activation following FAS stimulation, rather than blocking apoptotic signals downstream. May inhibit FAS-induced apoptosis by preventing CASP8 processing through CFLAR up-regulation. | |||
TMPJ-00280 |
TNF R1 Protein, Mouse, Recombinant
Tnfrsf1a,Tumor necrosis factor receptor superfamily member 1... |
Mouse | E. coli |
Tumor necrosis factor receptor superfamily member 1A (Tnfrsf1a) is a member of the tumor necrosis factor receptor superfamily. Tnfrsf1a is one of the major receptors for the tumor necrosis factor-alpha. It can activate the transcription factor NF-κB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the... | |||
TMPH-02613 |
ATF-5 Protein, Mouse, Recombinant (His & Myc)
Transcription factor ATFx,Transcription factor-like protein ... |
Mouse | E. coli |
Transcription factor that either stimulates or represses gene transcription through binding of different DNA regulatory elements such as cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), ATF5-specific response element (ARE) (consensus: 5'-C[CT]TCT[CT]CCTT[AT]-3') but also the amino acid response element (AARE), present in many viral and cellular promoters. Critically involved, often in a cell type-dependent manner, in cell survival, proliferation, and differentiation. Its transcrip... | |||
TMPH-02631 |
PRKN Protein, Mouse, Recombinant (GST)
|
Mouse | E. coli |
Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Substrates include SYT11 and VDAC1. Other substrates are BCL2, CCNE1, GPR37, RHOT1/MIRO1, MFN1, MFN2, STUB1, SNCAIP, SEPTIN5, TOMM20, USP30, ZNF746, MIRO1 and AIMP2. Mediates monoubiquitination as well as 'Lys-6', 'Lys-11', 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context. Participates in the removal and/or det... | |||
TMPH-01263 |
PRKN Protein, Human, Recombinant (His & SUMO)
|
Human | E. coli |
Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Substrates include SYT11 and VDAC1. Other substrates are BCL2, CCNE1, GPR37, RHOT1/MIRO1, MFN1, MFN2, STUB1, SNCAIP, SEPTIN5, TOMM20, USP30, ZNF746, MIRO1 and AIMP2. Mediates monoubiquitination as well as 'Lys-6', 'Lys-11', 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context. Participates in the removal and/or det... |